Sir,
We read the paper by Levy et al1 with interest, however, we believe that it contains several weaknesses which should be discussed.
As it is well known the diagnosis of GCA is based on the combination of clinical symptoms, laboratory test (CRP and ESR), and histopathology.2 The treatment must be started immediately, thus the temporal artery biopsy result usually confirms presumed diagnosis made on the basis of clinical picture and laboratory tests.
It is well known that laboratory tests in GCA have some limited sensitivity: CRP 86.9% and ESR 84.1%.2 Both combined gave specificity 97%, but it was shown and discussed in several studies that they might be normal in GCA:2, 3, 4, 5 ESR was normal in 5–30% of patients with GCA.3 The authors1 inappropriately stated that ‘including their case there are only three published cases of isolated CRP-negative GCA and only two cases of simultaneous ESR and CRP negativity' as they did not notice nor analyze many similar cases (Table 1). Noteworthy, it was postulated that elevated ESR with normal CRP might occur even in 1.7% of GCA patients,3 and that these markers can be normal at the early stage of the disease.4
Table 1. Some publications reporting normal ESR and/or CRP.
References | Normal ESR (number of cases/percentage of cases) | Normal CRP |
---|---|---|
Raja et al6 | 1 | 1 |
Rahman and Rahman7 | 5–30% | — |
Ellis and Ralston8 | 22.5% | — |
Kermani et al9 | 18 (4%) | 18 (4%) |
Man and Dayan10 | 1 | 1 |
Weintraub11 | 1 | — |
Wong and Korn12 | 36 | — |
Parikh et al13 | 1 (0.8%) | 2 (1.7%) |
Laria et al14 | 4–15% | 0.8% |
Yoeruek et al15 | 1 | 1 |
Myklebust and Gran16 | 1.2% | 1.2% |
Having in mind problems with ESR and CRP in GCA, the role of clinical picture of the disease seems to be very important. They include usually headache, tenderness of the scalp, jaw claudication and some systemic symptoms, including malaise, fever, anorexia, and weight loss.5 The symptoms are based on ischemia and/or inflammation. Thus, it is hard to understand why in the discussed case none of the clinicial symptomes was presented.
Concluding, we agree that diagnosis of GCA might be problematic, but it must be based on clinical picture and laboratory tests, including ESR and CRP, and confirmed by temporal artery biopsy. GCA with normal ESR and/or normal CRP level is rare, but many cases of this form of disease were already described.
The authors declare no conflict of interest.
References
- Levy SL, Bull AD, Nestel AR. How common is inflammatory marker-negative disease in giant cell arteritis. Eye. 2013;27:106–108. doi: 10.1038/eye.2012.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kermani TA, Schmidt J, Crowson CS, Ytterberg SR, Hunder GG, Matteson EL, et al. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum. 2012;41:866–871. doi: 10.1016/j.semarthrit.2011.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martínez-Taboada VM, Blanco R, Armona J, Uriarte E, Figueroa M, Gonzalez-Gay MA, et al. Giant cell arteritis with an erythrocyte sedimentation rate lower than 50. Clin Rheumatol. 2000;19:73–75. doi: 10.1007/s100670050017. [DOI] [PubMed] [Google Scholar]
- Hall JK. Giant-cell arteritis. Curr Opin Ophthalmol. 2008;19:454–460. doi: 10.1097/ICU.0b013e328310da01. [DOI] [PubMed] [Google Scholar]
- Grzybowski A, Misiuk-Hojlo M, Szalinski M. A need for new diagnostic tools for giant cell arteritis. Acta Ophthalmol. 2009;87:109. doi: 10.1111/j.1755-3768.2007.01165.x. [DOI] [PubMed] [Google Scholar]
- Raja MK, Proulx AA, Allen LH. Giant cell arteritis presenting with aortic aneurysm, normal erythrocyte sedimentation rate, and normal C-reactive protein. Can J Ophthalmol. 2007;42:136–137. [PubMed] [Google Scholar]
- Rahman W, Rahman FZ. Giant cell (temporal) arteritis: an overview and update. Surv Ophthalmol. 2005;50:415–428. doi: 10.1016/j.survophthal.2005.06.011. [DOI] [PubMed] [Google Scholar]
- Ellis ME, Ralston S. The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome. Ann Rheum Dis. 1983;42:168–170. doi: 10.1136/ard.42.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kermani TA, Schmidt J, Crowson CS, Ytterberg SR, Hunder GG, Matteson EL, et al. Utility of erythrocyte sedimentation rate and C-Reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum. 2012;41:866–871. doi: 10.1016/j.semarthrit.2011.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Man P, Dayan MR. Giant cell arteritis with normal inflammatory markers. Acta Ophthalmol Scand. 2007;85:460. doi: 10.1111/j.1600-0420.2006.00864.x. [DOI] [PubMed] [Google Scholar]
- Weintraub MI. Temporal arteritis. Arch Neurol. 1978;35:183. doi: 10.1001/archneur.1978.00500270065018. [DOI] [PubMed] [Google Scholar]
- Wong RL, Korn JH. Temporal arteritis without an elevated erythrocyte sedimentation rate. Case report and review of the literature. Am J Med. 1986;80:959–964. doi: 10.1016/0002-9343(86)90645-5. [DOI] [PubMed] [Google Scholar]
- Parikh M, Miller NR, Lee AG, Savino PJ, Vacarezza MN, Cornblath W, et al. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology. 2006;113:1842–1845. doi: 10.1016/j.ophtha.2006.05.020. [DOI] [PubMed] [Google Scholar]
- Laria A, Zoli A, Bocci M, Castri F, Federico F, Ferraccioli GF. Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein. Clin Rheumatol. 2012;31:1389–1393. doi: 10.1007/s10067-012-2031-3. [DOI] [PubMed] [Google Scholar]
- Yoeruek E, Szurman P, Tatar O, Weckerle P, Wilhelm H. Anterior ischemic optic neuropathy due to giant cell arteritis with normal inflammatory markers. Graefes Arch Clin Exp Ophthalmol. 2008;246:913–915. doi: 10.1007/s00417-007-0762-7. [DOI] [PubMed] [Google Scholar]
- Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol. 1996;35:1161–1168. doi: 10.1093/rheumatology/35.11.1161. [DOI] [PubMed] [Google Scholar]